"Being strong doesn't mean you aren't scared, it means you keep going despite it," Lana Nolan, who underwent two surgeries to ...

A study led by scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) has uncovered how the gut microbiome can influence gene activity in the liver by acting on short stretches of ...

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most ...

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say ...

ASCO 2026 data show daraxonrasib doubles survival in pancreatic cancer. MSK’s Mary Larsen discusses oral adherence and managing signature side effects. Following the landmark results of the RASolute ...

GLP-1 RA use is associated with a 38% to 42% lower risk for hepatic complications, including cirrhosis, among those with MASLD and T2D.

CIBMTR data shows manageable toxicity and outpatient potential for liso-cel in R/R MCL, emphasizing the vital role of nursing ...